These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 21071306)
1. [Fatty liver and global cardiometabolic risk]. Szollár L Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306 [TBL] [Abstract][Full Text] [Related]
2. From the metabolic syndrome to NAFLD or vice versa? Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [TBL] [Abstract][Full Text] [Related]
3. [Patomechanisms of hepatic steatosis]. Fülöp P; Paragh G Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747 [TBL] [Abstract][Full Text] [Related]
4. The central role of the non alcoholic fatty liver disease in metabolic syndrome. Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic steatohepatitis and the metabolic syndrome. Jiang J; Torok N Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830 [TBL] [Abstract][Full Text] [Related]
6. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. Pacana T; Fuchs M Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223 [TBL] [Abstract][Full Text] [Related]
18. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. Nomura K; Yamanouchi T J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639 [TBL] [Abstract][Full Text] [Related]
19. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280 [TBL] [Abstract][Full Text] [Related]